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A B S T R A C T   
Immune evasion is one of the unique characteristics of severe acute respiratory syndrome coronavirus 2 (SARS- 
CoV-2) attributed to its ORF8 protein. This protein modulates the adaptive host immunity through down- 
regulation of MHC-1 (Major Histocompatibility Complex) molecules and innate immune responses by surpass-
ing the host’s interferon-mediated antiviral response. To understand the host’s immune perspective in reference 
to the ORF8 protein, a comprehensive study of the ORF8 protein and mutations possessed by it have been 
performed. Chemical and structural properties of ORF8 proteins from different hosts, such as human, bat, and 
pangolin, suggest that the ORF8 of SARS-CoV-2 is much closer to ORF8 of Bat RaTG13-CoV than to that of 
Pangolin-CoV. Eighty-seven mutations across unique variants of ORF8 in SARS-CoV-2 can be grouped into four 
classes based on their predicted effects (Hussain et al., 2021) [1]. Based on the geo-locations and timescale of 
sample collection, a possible flow of mutations was built. Furthermore, conclusive flows of amalgamation of 
mutations were found upon sequence similarity analyses and consideration of the amino acid conservation 
phylogenies. Therefore, this study seeks to highlight the uniqueness of the rapidly evolving SARS-CoV-2 through 
the ORF8.   
1. Introduction 
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is a 
novel coronavirus whose first outbreak was reported in December 2019 
in Wuhan, China, where a cluster of pneumonia cases was detected. In 
March 11, 2020, WHO declared this outbreak a pandemic [2–5]. As of 
March 30, 2021, a total of 127.8 million confirmed COVID-19 cases had 
been reported worldwide, with 2.8 million deaths (World Health 
Fig. 1. Landscape of ORF8 protein. (A) 
Genomic organization of SARS-CoV-2 
genome highlighting the ORF8 region with 
vdW and cartoon representation of the ORF8 
structure. (B) The SARS-CoV-2 ORF8 protein 
structure (surface representation) showing 
2.04 Å resolution by X-ray crystallography 
bearing PDB ID: 7JTL. (Below) Schematic 
illustration of the ORF8 dimer structure 
(Chain A (blue) and B (turquoise)) depicting 
disulfide bonds showing both intermolecular 
and intramolecular bond pairing. (C) Sche-
matic illustration of immune invasion 
mechanism of ORF8 overexpression that 
modulates downregulation MHC-1 complex. 
This figure was created with Biorender.com.   
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Organization. Coronavirus disease 2019 (COVID-19) situation). 
SARS-CoV-2 belongs to the family Coronaviridae and has 55% nucleo-
tide similarity and 30% protein sequence similarity with SARS-CoV, 
which caused the outbreak of SARS in 2002 [6–8]. SARS-CoV-2 is an 
enveloped, single-stranded RNA virus of positive polarity whose genome 
is approximately 30 kb in length and encodes 16 non-structural proteins, 
four structural, and six accessory proteins [9–11], ORF3a, ORF6, ORF7a, 
ORF7b, ORF8, and ORF10 (Fig. 1A) [12–16]. Among these accessory 
proteins, SARS-CoV-2 ORF8 is a complete protein, as it is different from 
any other known coronavirus ORF8 and thereby can be associated with 
SARS-CoV-2 pathogenicity [17,18]. The SARS-CoV-2 ORF8 displays 
arrays of functions; inhibition of interferon 1, promotion of viral repli-
cation, induction of apoptosis, and modulation of the ER stress [19–21]. 
The SARS-CoV-2 ORF8 is a 121 amino acid (aa) long protein, which 
has an N-terminal hydrophobic signal peptide (1–15 aa), and an ORF8 
chain (16–121 aa) bearing dimer crystallography determined to 2.04 Å 
(PDB-ID:7JTL) (Fig. 1B) [22,23]. The functional motif (VLVVL) of 
SARS-CoV ORF8b, responsible for the induction of cell stress pathways 
and activation of macrophages, is absent from the SARS-CoV-2 ORF8 
protein [24]. In the later stages of the SARS-CoV epidemic, it was found 
that a 29 nucleotide deletion in the ORF8 protein caused it to split into 
ORF8a (39 aa) and ORF8b (84aa), rendering it functionless [25]. 
Although such deletions have not been reported for SARS-CoV-2, a 
382-nucleotide deletion variant (Δ382) was identified in Singapore and 
other countries, which caused the deletion of the entire ORF8 protein 
[26]. Patients with the Δ382 variant exhibited less severe symptoms, 
including milder hypoxic conditions and low cytokine activity compared 
to patients infected with the wildtype virus [26]. Also, the SARS-CoV-2 
ORF8 functions in interspecies transmission and viral replication effi-
ciency as the Δ382 deletion variant resulted in a reduced viral replica-
tion ability in human cells [27]. However, the SARS-CoV-2 ORF8 mainly 
acts as an immune-modulator by down-regulating MHC class I mole-
cules, thereby shielding the infected cells against cytotoxic T cells, 
killing the target cells (Fig. 1C). Simultaneously, it is a potent inhibitor 
of the type 1 interferon signaling pathway, a key component of antiviral 
host immune response [28,29]. The ORF8 also regulates unfolded pro-
tein response (UPR) induced due to the ER stress by triggering the ATF-6 
activation, thus enhancing the survivability of infected cells [30]. Since 
this protein impacts various host processes and develops various stra-
tegies for evading the host immune responses, it is essential to study the 
ORF8 mutations (natural variability) to understand better the viral 
infectivity and development of potent antiviral drugs against 
SARS-CoV-2 [31]. 
The present study identified a set of distinct mutations across unique 
variants of the SARS-CoV-2 ORF8 and classified them according to their 
predicted effect on the host (i.e., disease or neutral) and their conse-
quences for protein structural stability. Furthermore, a comparison of 
the ORF8 protein of SARS-CoV-2 with Bat-RaTG13-CoV and Pangolin- 
CoV ORF8 was conducted to determine the evolutionary relationships 
regarding sequence similarity and originality of these paralogues. 
Similarly, a hydropathy and charge examination of the SARS-CoV-2 
ORF8 mutations in distinct domains were executed to explore the 
possible effect on functionality changes. A possible flow of mutations 
scales simultaneously concerning the different geographical locations 
and chronological time has been depicted through phylogenetic anal-
ysis. Hence, validating the proposed sequence-based and amino acid 
conservation-based phylogeny is critical. 
2. Results 
2.1. Structural view of SARS-CoV-2 ORF8 protein in comparison to 
SARS-CoV 
The SARS-CoV-2 ORF8 protein (YP 009724396) is a 121-amino-acid- 
long protein, which has an N-terminal hydrophobic signal peptide (1–15 
aa) and an ORF8 chain (16–121 aa). Fig. S1 shows a schematic 
representation of ORF8 (SARS-CoV-2). In this protein, the total number 
of hydrophilic residues (63) was more extensive than that of the hy-
drophobic residues (58). The ORF8 protein of SARS-CoV-2 has only 
55.4% nucleotide and 30% amino acid similarity with SARS-CoV, as 
shown in Fig. S2. Although the SARS-CoV-2 ORF8 has different genome 
characteristics, it exhibits high functional similarity with SARS-CoV 
ORF8ab. The ORF8 of SARS-CoV-2 consists of a 60-residue core 
similar to SARS-CoV-2 ORF7a (PDB-ID:6W37), with the addition of two 
dimerization interfaces unique to SARS-CoV-2 ORF8 (Fig. 2A). The su-
perimposition of ORF7a, ORF8a, and ORF8b of SARS-CoV revealed 
significant insights into the SARS-CoV-2 ORF8 protein architecture. The 
Root Mean Square Deviation and (Secondary structure matching (Q 
score) [32] depicted a deviation of 3.206 Å, 2.301 Å, 1.007 Å and 0.078, 
0.036, and 0.621 when the SARS-CoV proteins were superimposed with 
ORF8 protein of SARS-CoV-2. From the aforementioned analysis, SAR-
S-CoV ORF8b showed a high degree of similarity as a greater Q score 
represents high similarity, whereas ORF7a and ORF8a consist of less 
similarity with the ORF8 of SARS-CoV-2. The SARS-CoV ORF8ab orig-
inal protein possesses an N-terminal hydrophobic signal sequence, 
which directs its transport to the endoplasmic reticulum (ER). However, 
after deleting the 29 nucleotides, which splits the ORF8ab protein into 
ORF8a and ORF8b, only ORF8a can translocate to the ER, and ORF8b 
remains distributed throughout the cell. Likewise, the SARS-CoV-2 
ORF8 protein also contains an N-terminal hydrophobic signal peptide 
(1–15 aa), which is involved in the same function. The ER has an internal 
oxidative environment akin to other organelles, necessary for correct 
protein folding and oxidation processes. Due to this oxidative environ-
ment, the formation of intra or intermolecular disulfide bonds between 
unpaired cysteine residues can occur as the SARS-CoV ORF8ab protein is 
an ER-resident protein. There are ten cysteine residues present in ORF8 
of SARS-CoV, which can be involved in disulfide linkages leading to the 
formation of homomultimeric complexes in the ER. Similarly, the ORF8 
of SARS-CoV-2 also has seven cysteines, which may be expected to form 
these types of disulfide linkages. 
Upon inspection of the SARS-CoV-2 ORF8 protein, it was found that 
it consists of two domains, named D1 and D2, in which D1 consists of a 
signal peptide and D2 consists of the ORF8 domain. The most conserved 
region in the ORF8 protein of SARS-CoV-2 is “PFTINCQE” (highlighted 
in green) which is present in the catalytic core of the protein (Fig. 2B). 
The dimeric form of the protein consists of intermolecular disulfide 
bonds formed by Cys20 (yellow color) of each monomer (Chain A and B) 
(Fig. 2C). The ORF8 monomer also comprises of two-antiparallel 
β-sheets (smallest sheet with β2, β5, and β6 and the larger one with 
β3, β4, β7, and β8 where β8 is linked to β1). The dimer structure of SARS- 
CoV-2 ORF8 i.e., Chain A, interfaces with Chain B involving 1 disulfide 
bond, 4 salt bridges, 12 hydrogen bonds, and 70 non-bonded contacts. 
Most of the interface residues that are involved in interactions are 
aliphatic amino acids (grey color) followed by positive amino acids (blue 
color) (Fig. 2C). The SARS-CoV ORF8ab is characterized by an aspara-
gine residue at position 81 with the Asn-Val-Thr motif responsible for 
the N-linked glycosylation SARS-CoV-2 ORF8 has an N-linked glyco-
sylation site at Asn78, and its glycosylation motif is Asn-Tyr-Thr 
(Fig. 3A). Val77 in SARS-CoV ORF8b has been pointed out to play a 
critical role in the induction of the intracellular aggregation, lysosomal 
stress, and interleukin-mediated inflammatory responses by activating 
NLRP3 inflammasomes [33]. Furthermore, Val77 is conserved in 
SARS-CoV-2 (Wuhan strain) and the recently identified British variation 
SARS-CoV-2/B.1.1.7 [1,34], contributing to the pathological manifes-
tation of infections. SARS-CoV-2/B.1.1.7 may have an evolutionary 
advantage over SARS-CoV-2/Wuhan based not only on antigenic 
changes in the spike and ORF8 proteins but also on enhanced 
cytokine-mediated inflammatory responses because of intracellular ag-
gregation in host cells. The SARS-CoV-2 ORF8 is engaged in 
protein-protein and protein-DNA interactions, while SARS-CoV ORF8ab 
shows only protein-protein interactions [35]. Most conserved regions in 
SARS-CoV-2 ORF8 lie around the helix-coil and strand-coil junctions, 
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signifying these regions’ functional importance. Predicted α-helical re-
gions were also found to have conserved amino acids. It could be hy-
pothesized that these junctions are involved in protein-protein 
interactions, and consequently, these regions are naturally conserved 
(Table S1 and Fig. S3). Our findings agree with recently published data 
on conserved regions in the SARS-CoV-2 ORF8 [36]. 
2.2. Proximal evolutionary origin of the SARS-CoV-2 ORF8 in 
comparison to bat-RaTG13-CoV-ORF8 and pangolin-CoV-ORF8 
The ORF8 protein sequences of Pangolin-CoV and Bat-RaTG13-CoV 
were aligned against SARS-CoV-2 ORF8 amino acid sequence to un-
derstand the proximal evolutionary origin of the SARS-CoV-2 ORF8 
protein. The unique ORF8 variants of Pangolin-CoV sequences 
(QIA48620.1, QIA48638.1, QIA48647.1, and QIQ54055.1) were 
aligned, which suggested that the Pangolin-CoV ORF8 protein is 
conserved. There are three available ORF8 sequences of Bat-RaTG13- 
CoV (AVP78048.1, AVP78037.1, and QHR63307.1), of which two var-
iants (QHR63307.1 and AVP78048.1) have turned out to be character-
ized by 96% sequence similarity, where mutations L3F, T14A, K44R, 
F104Y, and V114I were embedded in the ORF8 sequences of Bat- 
RaTG13-CoV (Fig. 3B and Fig. S4). Furthermore, the ORF8 protein of 
SARS-CoV-2 is very much similar (95%) to that of Bat-RaTG13-CoV 
based on sequence similarity as well as phylogenetic relationships 
(Fig. 6). Sequence alignment indicates six amino acid differences be-
tween the ORF8 from SARS-CoV-2 and Bat-RaTG13-CoV (Fig. S5). 
We have also aligned the Pangolin-CoV ORF8 (QIQ54055.1 ORF8 
protein) sequence with SARS-CoV-2 (YP 009724396.1 ORF8 protein) 
and found that there is a sequence similarity of 88%, as depicted in Fig. 
S6. We observed a difference of 15 amino acid residues between the 
Pangolin-CoV and SARS-CoV-2 ORF8. It was established that in both the 
Bat-RaTG13-CoV and Pangolin-CoV ORF8 proteins, the mutations L10I, 
V65A, and S84L were present. So, it can be hypothesized that the SARS- 
CoV-2 ORF8 may have originated from Pangolin-CoV or Bat-RaTG13- 
CoV ORF8. 
In terms of structural alignment, when the SARS-CoV-2 ORF8 protein 
structure was superimposed against Bat-RaTG13-CoV and Pangolin-CoV 
ORF8, it was observed that both Bat-RaTG13-CoV and Pangolin-CoV 
ORF8 structure contains a small helix which was not observed in the 
SARS-CoV-2 ORF8 structure (PDB-ID:7JTL) (Fig. 4A). The helix region’s 
difference consists of Val49, Gly50, and Ala51, which has evolved as a 
beta-hairpin structure in the SARS-CoV-2 ORF8 structure. The amino 
Fig. 2. Structure-based alignment of 
SARS-CoV-2 ORF8. (A) Superimposition of 
SARS-CoV-2 ORF8 with SARS-CoV ORF7a, 
SARS-CoV ORF8a and SARS-CoV ORF8b 
protein structures illustrating Q score and 
RMSD. (B) SARS-CoV-2 ORF8 surface struc-
ture bearing conserved region and D2 
domain (protein dimer chains A (violet) and 
B (red)). (Below) Schematic illustration of 
the SARS-CoV-2 ORF8 structure depicting 
anti-parallel β sheets (β1-β8). N and C 
termini are labeled accordingly. The green 
color shows the conserved region of the 
SARS-CoV-2 ORF8 protein. (C) Interaction 
between the interface residues between the 
two chains A and B (ORF8 dimer) showing 
bonding patterns.   
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acid difference between all three sequences depicted in Fig. 4B shows 
that the conserved region PFTINCQE has been conserved in all three 
species. Comparison of the secondary structure of ORF8 proteins from 
SARS-CoV-2, Bat-RaTG13-CoV, and Pangolin-CoV indicates changes at 
four different locations (Table S2). From Table S2, it is inferred that the 
secondary structures of ORF8 (SARS-CoV-2) and Bat-RaTG13-CoV are 
closely related compared to the ORF8 of Pangolin-CoV. Based on the 
sequence alignment, the ORF8 of SARS-CoV-2 differs substantially from 
the ORF8 of Pangolin-CoV in terms of a greater number of amino acid 
differences (mutations). It can be hypothesized that the SARS-CoV-2 
ORF8 protein is using ORF8 of Bat RaTG13-CoV as a blueprint of its 
structure. 
2.3. Evaluating the propensity of various ORF8 proteins for intrinsic 
disorder 
The differences between the ORF8 of SARS-CoV-2, Bat-RaTG13-CoV, 
and Pangolin-CoV can be further demonstrated by analyzing the per- 
residue intrinsic disorder predispositions of these proteins. Results of 
this analysis shows the results in Fig. 4C, which illustrates that the 
intrinsic disorder propensity of the ORF8 from SARS-CoV-2 is closer to 
that of the ORF8 from Bat-RaTG13-CoV than to the disorder potential of 
ORF8 from Pangolin-CoV. This agrees with the results of the analyses 
mentioned above conducted in this study. Because SARS-COV-2 ORF8 is 
closer to Bat-RaTG13-CoV, we then analyzed the variants of SARS-CoV-2 
ORF8 itself (96 variants) to shed light on the possible effect of mutations 
on disorder profiles within the variants of ORF8. When all the 96 variant 
sequences were aligned, it was observed that 6.6% of the region is 100% 
evolutionary conserved across all 96 distinct variants of the 121-amino- 
acid-long ORF8 protein, including the largest conserved region 
PFTINCQE’ (in D2 domain) (Fig. S2) in the ORF8 protein of SARS-CoV-2. 
The intrinsic disorder profile analysis revealed that the intrinsic disorder 
predispositions could vary significantly, especially in highly and 
moderately flexible regions (among 96 variants) (Fig. 4D). Although 
many mutations are disorder-silent, some increase the local disorder 
propensity, whereas others cause a noticeable decrease in disorder 
Fig. 3. (A) SARS-CoV-2 ORF8 monomer and SARS-CoV ORF8b showing N-linked glycosylation sites analyzed through NetNGlyc 1.0. The N-linked glycosylation sites 
are marked red. (B) Structural alignment of two ORF8 sequences (116 among 121 residues was identical) of Bat-RaTG13-CoV QHR63307.1 and AVP78048.1, 
illustrating mutations at particular sites. The same presentation using Web Logo server. 
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predisposition. For example, local disorder predisposition in the vicinity 
of residue 20 was increased in the variants QKV39247.1 and 
QLC47867.1. Variants QMT50144.1 and QLH01532.1 have a prominent 
new peak in the vicinity of residue 30, where most other variants have a 
shoulder. Although variant QJS56890.1 also has a prominent peak in 
residue 30 and has one of the highest peaks in the vicinity of residue 50, 
the intensity of its peak in the vicinity of residue 20 is noticeably 
decreased. Variant QMT96539.1 showed higher disorder propensity in 
the vicinity of residue 110. Variants QMT49652.1 and QMT54388.1 
have the lowest disorder predisposition in residue 50, whereas the 
lowest disorder propensity in the vicinity of residue 70 is found in var-
iants QKV06506.1 and QKQ29929.1. Finally, although variant 
QMU91370.1 is almost indistinguishable from variant QJS56890.1 
within the first 40 residues, its intrinsic disorder predisposition in the 
vicinity of residue 70 is one of the lowest among all proteins analyzed in 
this study. Comparison of Fig. 4C and D shows that the variability in the 
disorder predisposition between many variants of the ORF8 protein from 
SARS-CoV-2 isolates is noticeably greater than that between the refer-
ence ORF8 from SARS-CoV-2 and ORF8 proteins from Bat-RaTG13-CoV 
and Pangolin-CoV. 
One could ask how these disorder predictions would correlate with 
the actual structure of the ORF8 protein from SARS-CoV-2. Recently, 
two crystal structures of this protein’s dimeric form were reported, PDB 
ID: 7JTL and PDB ID: 7JX6 [41] Fig. S7 represents the results of multiple 
structure alignments of four ORF8 chains found in these structures, 
chains A and B of 7JTL and chains A and B of 7JX6. Despite high overall 
structural similarity (87 residues are aligned with the root mean square 
deviation, RMSD, of 0.57 Å), Fig.S7 shows that several loop regions are 
characterized by relatively high structural flexibility, with the highest 
flexibility being found in the 63–78 loop. Curiously, this long loop is 
characterized by high structural plasticity, being very differently present 
in different ORF8 chains. In fact, in the 7JX6 dimer, it is entirely missing 
in the chain B structure but exists as a loop with two short β-strands 
(residues 61–63 and 68–70) in the chain A structure. In the 7JTL dimer, 
residues 63–68 are missing. Note that residues 15–18 are missing in this 
structure as well. Fig. 4D provides an outlook of the correlation between 
the intrinsic disorder predisposition of ORF8 protein and its structure. It 
is seen that most stable secondary structure elements (8 β-strands shown 
by light cyan vertical bars) are preferentially located within regions with 
low intrinsic disorder propensity, whereas the structurally mobile 63–78 
loop is predicted to be highly flexible. 
The conformational flexibility of the ORF8 protein could be 
Fig. 4. Comparative sequence and struc-
tural analysis of SARS-CoV-2, Bat-CoV- 
RaTG13, and Pangolin-CoV ORF8. (A) Sec-
ondary structure analysis of ORF8 protein 
structures. Rounded circle represents the 
helix region (green color). The β sheets are 
illustrated using ChimeraX (violet color). (B) 
Web logo presentation of the species’ aligned 
sequences mentioned above of ORF8 amino 
acid sequences depicting the mismatches (ar-
rows). The dotted arrows indicates all mis-
matches across the aligned sequences. (C) 
Comparison of the intrinsic disorder predis-
position of the reference ORF8 protein (YP 
009724396.1) of the NC 045512 SARS-CoV-2 
genome from Wuhan, China (bold red curve) 
with disorder predispositions of ORF8 from 
the Pangolin-CoV (QIA48620.1) and Bat- 
RaTG13-CoV (QHR63307.1). (D). Analysis of 
the intrinsic disorder predisposition of the 
unique variants of the SARS-CoV-2 ORF8 in 
comparison with the reference ORF8 protein 
(YP 009724396.1) from the NC 045512 SARS- 
CoV-2 genome from Wuhan, China (bold red 
curve). Analysis was conducted using the 
PONDR® VSL2 algorithm [37], one of the 
more accurate standalone disorder predictors 
[37–40]. A disorder threshold is indicated as a 
thin line (at score = 0.5). Residues/regions 
with disorder scores >0.5 are considered as 
disordered. Light cyan vertical bars represent 
positions of β-strands, whereas light pink and 
light-yellow vertical bars show regions with 
missing electron density in the crystal struc-
tures of the ORF8 protein from SARS-CoV-2 
(PDB ID: 7JILB and 7JX6, respectively).   
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responsible for or mediating unique immune suppression and immune- 
evasion capabilities of SARS-CoV-2, which may contribute to the high 
transmissibility and vigorous pathogenesis of this virus [42]. Although 
at early stages of pandemics, the ORF8 protein was shown to be an 
immunogenic secreted protein that induces neutralizing antibodies and 
can be utilized for the accurate diagnosis of COVID-19 [43], the pres-
ence of multiple ORF8 mutations requires a systematic analysis of its 
peptide map to determine the effects of these mutations on the 
neutralization potential of the ant-ORF8 antibodies, which may have 
therapeutic and/or diagnostic values. 
2.4. Shedding light on physicochemical properties of ORF8 across SARS- 
CoV-2, bat-RaTG13-CoV, and Pangolin-CoV 
As the analyses mentioned above showed the similarity profile based 
on sequence and structure alignments, awareness of the physicochem-
ical properties of the SARS-CoV-2 ORF8 protein is required to under-
stand the composition of these viral proteins to develop subunit vaccines 
or for designing drugs targeting these specific proteins [44]. Physico-
chemical analysis revealed that the total number of hydrophilic residues 
in the SARS-CoV-2 ORF8 protein was higher than that of the hydro-
phobic residues [24]. However, the predicted secondary structure and 
solvent accessibility analysis (Fig. S8) indicated that the highest solu-
bility score for this protein is four, indicating that although hydrophilic 
residues are higher in number, they are insufficient to ensure high 
protein solubility. Fig. S8 shows the predicted secondary structure and 
solvent accessibility of the ORF8 proteins of SARS-CoV-2, 
Bat-RaTG13-CoV, and Pangolin-CoV obtained using the ab-initio web 
server QUARK to perceive the differences. The frequencies of the hy-
drophobic, hydrophilic, and charged amino acids were compared among 
the four ORF8 proteins of SARS-CoV, SARS-CoV-2, Bat-RaTG13-CoV, 
and Pangolin-CoV. As seen in Table S3, SARS-CoV-2 ORF8, 
Bat-RaTG13-CoV ORF8, and Pangolin-CoV ORF8 are all similar in terms 
of hydrophobicity and hydrophilicity, and it is known that hydropho-
bicity and hydrophilicity play an essential role in protein folding, which 
determines the tertiary structure of the protein and thereby affects the 
functions of ordered proteins. The ORF8 sequences of SARS-CoV-2, 
Bat-RaTG13-CoV, and Pangolin-CoV have almost the exact content of 
positive and negative charged amino acids. Therefore, we can hypoth-
esize that these proteins probably have similar electrostatic and 
Fig. 5. Comparison of global biophysical 
properties of ORF8 proteins of SARS-CoV- 
2, Bat-RaTG13-CoV, and Pangolin-CoV. 
(A–D) A pairwise matrix of correlation co-
efficients between SARS-CoV-2 ORF8, Bat- 
RaTG13-CoV ORF8, and Pangolin-CoV 
ORF8 has been illustrated based on default 
parameters, the Pearson correlation coeffi-
cient R and the Spearman rank correlation 
coefficient using VOLPES in terms of the 
level of similarity between physicochemical 
properties i.e., hydrophobicity, pH7.0, beta 
propensity, and relative mutability, respec-
tively. High values (cyan) and lower values 
(green) color represent correlation coeffi-
cient values. The individual panel across 
rows was compared against each other, and 
the coefficients were calculated. Similarly, 
each panel across rows was calculated. For 
instance, in Fig. 5A, R = 1 represents the 
hydrophobicity correlation of SARS-CoV-2 
ORF8 with SARS-CoV-2 ORF8. Similarly, R 
= 0.97 represents the similarity between 
SARS-CoV-2 ORF8 with BatRatG13-CoV 
ORF8 across the same row. (E–H) Physico-
chemical properties, i.e., Theoretical pI, 
Instability Index, GRAVY, and Aliphatic 
index of ORF8, were calculated using Prot-
Param, respectively.   
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hydrophobic interactions, contributing to their functionality. Again, for 
the SARS-CoV ORF8ab, it was found that the number of positively and 
negatively charged amino acids are similar to those of the SARS-CoV-2 
ORF8. Although the SARS-CoV sequence bears less similarity with the 
SARS-CoV-2, these proteins are likely similar in terms of electrostatic 
and hydrophobic interactions as well. 
Moreover, a pairwise matrix of correlation coefficients between 
SARS-CoV-2 ORF8, Bat-RaTG13-CoV ORF8, and Pangolin-CoV ORF8 has 
been illustrated based on default parameters, the Pearson correlation 
coefficient R and the Spearman rank correlation coefficient using 
VOLPES [24] in terms of the level of similarity between physicochemical 
properties i.e., hydrophobicity [45] (Fig. 5A), pH7.0 (Fig. 5B), beta 
propensity (Fig. 5C) and relative mutability [46] (Fig. 5D). The analysis 
revealed that in most properties, SARS-CoV-2 ORF8 has a high corre-
lation with BatRatG13-CoV ORF8 protein and shows less correlation 
with Pangolin-CoV ORF8. However, BatRatG13-CoV ORF8 and 
Pangolin-CoV ORF8 share an excellent correlation. Since we have pre-
viously explored the amino acid changes based on multiple sequence 
alignments, the relative mutability factor may shed light on the simi-
larity correlation between SARS-CoV-2 and BatRatG13-CoV, proving 
that SARS-CoV-2 is closer to BatRatG13-CoV. 
Furthermore, we analyzed three ORF8 sequences and checked their 
molecular weights, isoelectric points (pIs) (Fig. 5E), Instability index 
(Fig. 5F), hydropathy (GRAVY) (Fig. 5G), Aliphatic Index (Fig. 5H), net 
charge, and extinction coefficient using a peptide property calculator 
(https://pepcalc.com/) (Fig. S9) and ProtParam. We found that all 
properties are almost similar between the SARS-CoV-2 and the 
BatRatG13-CoV ORF8 protein. While inspecting the chemical aspects, e. 
g., molecular weight, the ORF8 protein of Bat-RaTG13-CoV, Pangolin- 
CoV, and SARS-CoV-2 are very closely related based on their chemical 
aspects of amino acid residues (Fig. S9). The isoelectric point (pI) and 
the protein’s molecular weight tell us about the protein’s biochemical 
and functional aspects. Since the ORF8 sequences of Bat-RaTG13-CoV 
and SARS-CoV-2 have the same pI and molecular weights, they can be 
grouped under a single functional header. The pI of the Pangolin-CoV 
ORF8 is higher than that of the SARS-CoV-2 ORF8, indicating that the 
ORF8 of the Pangolin-CoV is more negatively charged than the SARS- 
CoV-2 ORF8. 
2.5. Natural variants of SARS-CoV-2 ORF8 protein 
Each of the ORF8 amino acid sequences (96 variants) was aligned 
concerning the ORF8 protein (YP 009724396.1) from Wuhan, China, 
using the multiple sequence alignment tools (NCBI Blastp suite), and the 
corresponding results were used to identify mutations and their associ-
ated positions [47]. It is noted that a mutation from an amino acid A1 to 
A2 at a position p is denoted by A1pA2 or A1(p)A2. Fig. 6 and Table S4 
describe various mutations with their respective locations. The missense 
mutations were found within the entire ORF8 sequence starting from the 
amino acid position 3 to 121, and some insertion mutations occurred at 
Fig. 6. Mutational profiling and their amino acid 
positions in ORF8 proteins of SARS-CoV-2 (96 
variants). (Upper left) Frequency distribution of 
various mutations in the ORF8 protein variants (96 
variants) of SARS-CoV-2. A red circle marked the 
mutations (Single Nucleotide Polymorphism (SNP)), 
Deletions with green/black, and Insertions with 
cyan/blue. (Upper left) Structural representation of 
SARS-CoV-2 ORF8 monomer showing high-frequency 
mutations. Below each sequence, a 2D presentation of 
the secondary structure plot has been depicted using 
PDBsum. (β Strands are presented in blue with 
naming convention as A (long β strands) and B (short 
β strands)).   
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the end of the C-terminal region. Furthermore, it was discovered that 
several positions within the amino acid sequence of SARS-CoV-2 ORF8 
protein might have more than one mutation [36]. For example, at po-
sition 11, which is a threonine (T) in a reference ORF8 protein, one 
might find isoleucine (I), alanine (A), or lysine (K) in some SARS-CoV-2 
ORF8 natural variants. Based on the observed mutations in different 
ORF8 variants, it is noticed that threonine (T) and tryptophan (W) are 
the most vulnerable for mutations. It is noteworthy that the SARS-CoV-2 
ORF8 is rapidly undergoing mutational changes, indicating that it is a 
highly evolving protein, whereas the Bat-RaTG13-CoV ORF8 (Fig. S5) 
and the Pangolin-CoV ORF8 are highly conserved (Fig. S6). A list of 
mutations and their frequency distributions is presented in Table S5, 
along with a histogram plot (Fig. 6 (upper left)). Structural representa-
tion of a single chain ORF8 protein depicting the high-frequency mu-
tation has been shown in (Fig. 6 (upper right)). 
The N-terminal signal peptide of ORF8 (D1) of SARS-CoV-2 is hy-
drophobic. We further analyzed mutations within this region and 
observed that hydrophobic to hydrophobic mutations were dominating, 
indicating that the domain’s hydrophobicity is maintained (Table S6). 
Therefore, we can postulate that there are probably no functional 
changes in the hydrophobic N-terminal signal peptide associated with 
the evolutionary variability. Furthermore, it was found that there was a 
change from hydrophilic to hydrophobic residues in two positions of the 
D1 region, thereby further enhancing its hydrophobic nature. Although 
hydrophobic to hydrophilic and hydrophilic to hydrophilic mutations 
were also observed, they were not expected to have significant effects 
when compared to hydrophobicity changes, as hydrophobic mutations 
were observed at eight positions. 
In contrast, hydrophilic mutations were only present at five posi-
tions. The ORF8 chain (D2) was demonstrated to be a region enriched in 
mutations affecting hydrophilic residues, with corresponding mutations 
being found in thirty-eight positions. Out of all mutations, only twenty- 
three mutations were affecting hydrophobic residues in D2. 
2.6. Mutation profiling of SARS-CoV-2 ORF8 natural variants 
Distinct, non-synonymous mutations and the associated frequency of 
mutations predicted effects (using Meta-SNP), as well as the predicted 
changes in the structural stability (using I-MUTANT) due to mutation(s), 
are presented in (supplementary table S1). The most frequent mutation 
in the ORF8 proteins turned out to be L84S (hydrophobic (L) to non- 
charged hydrophilic (S)), which is a clade (S) determining mutation 
with the frequency of 23 (Hosseini Rad Sm and McLellan 2020). The 
results suggest that the L84S mutation decreases structural stability and 
can change the ORF8 functions. Based on the predicted effects and 
changes of stability, we classified the mutations into four types Table S7: 
Disease-Decreasing: This class includes disease mutations that are 
decreasing the stability of the protein, with most of them occurring in 
D2; Neutral-Decreasing: Although the mutations are of a neutral type 
and supposedly are not harmful to the host, they cause protein structure 
stability to decrease; Disease-Increasing: These mutations lie within the 
D1; they increase the protein’s stability, making the hydrophobic N- 
terminal more stable and thereby making the localization of ORF8 to ER 
more efficient; Neutral-Increasing: The frequency of mutations is very 
low in this class, although the mutations are neutral, they increase the 
protein’s stability effectively, and they all occur in the D2 domain 
(supplementary table S2). Supplementary tables S3 and S4 list unique 
ORF8 protein IDs and their associated mutations with domain(s), and 
the predicted effects and changes of structural stability are presented. 
Furthermore, based on the three different types of mutations viz. 
neutral, disease, and mix of neutral & disease, all ORF8 proteins are 
classified into three groups, which are presented in (supplementary 
table S5). It was concluded that most mutations examined in the distinct 
variants of the ORF8 proteins of SARS-CoV-2 turned up to be neutral, 
while 42% of the mutations become disease-causing as predicted. 
Furthermore, based on their abundance in several SARS-CoV-2 ORF8 
variants, mutations S24L (which is present in 27 variants) and L84S 
(which was found in 23 variants) can be classified as strain-determining. 
Notably, one of them (L84S) was already defined in the literature [48]. 
Tables S6 and S7 represent the lists of ORF8 protein IDs and associated 
details on sequences with these two strain-determining mutations. Note 
that there are 64 ORF8 sequences, which do not possess 
strain-determining mutations. This high mutational variability suggests 
that the ORF8 protein is undoubtedly one of the essential proteins, 
which directs the pathogenicity of a variety of strains of SARS-CoV-2. 
2.7. Remarks based on mutations over ORF8 proteins of SARS-CoV-2, 
bat-RaTG13-CoV, and Pangolin-CoV 
Next, we compared the SARS-CoV-2 ORF8 with the Bat-RaTG13-CoV 
and the Pangolin-CoV ORF8 to study mutation evolution. The mutations 
in the ORF8 protein regarding the reference ORF8 sequence of Bat- 
RaTG13-CoV were found to be of the neutral type as predicted 
through the webserver Meta-SNP. All of them are expected to cause a 
decrease in ORF8 stability as determined using the server I-MUTANT 
(Fig. S5). The detailed analysis of all mutations is presented in Table S8. 
Based on these data, it can be suggested that several mutations in SARS- 
CoV-2 ORF8 can be considered as a reversal mutation. These are mu-
tations at specific positions in the SARS-CoV-2 ORF8, which are 
substituted by the residues present in the Bat-RaTG13-CoV and the 
Pangolin-CoV ORF8 proteins. The results indicate that some positions in 
the SARS-CoV-2 ORF8 represent a kind of reverse genetic engineering 
compared with the Bat-RaTG13-CoV and the Pangolin-CoV ORF8 
(Table S9). 
2.8. Possible flow of mutations in ORF8 evolution 
Here we present five different possible mutation flows according to 
data collection of the virus samples from patients [49,50]. Sequence 
homology and amino acid composition-based phylogenies have been 
drawn for the associated ORF8 proteins in each flow. Note that the ORF8 
sequence QLJ93922.1 (USA) possesses consecutive (38–46 aa) deletion 
mutations. The other sequence, QKI36860.1 (Guangzhou, China) ac-
commodates four insertion mutations at the end of the C-terminal region 
(122–125) along with two other mutations, S84L and D119E. 
2.9. Flow-I 
In this flow of mutations, we have described the occurrence of mu-
tations in the US sequences based on chronological order, considering 
the Wuhan ORF8 sequence YP 009724396 as the reference sequence 
(Fig. 7). The protein sequence QMI92505.1 possesses a mutation L4F of 
neutral type with no change in hydropathy. However, it showed a 
decreasing effect on the stability of the protein. Following this sequence, 
another sequence, QMT48896.1, was identified following the time scale, 
in which a second mutation located at D63 N emerged. This mutation is 
of neutral type, and no change in hydropathy was observed. Therefore, 
this sequence accumulated two neutral mutations, which may affect the 
protein’s function as both mutations cause a decrease in protein stabil-
ity. The QMT96239.1 sequence harbors another mutation, G8R, which is 
of the disease-increasing type, and the hydropathy changed from hy-
drophobic to hydrophilic. Another mutation, D35Y, occurred as a 
second-order mutation in the QMU92030.1 sequence in addition to the 
G8R mutation. As D35Y is neutral and G8R is of the disease-increasing 
type, their combination may alter both the protein’s structure and 
function. To support these mutation flows, we analyzed the protein 
sequence similarity based on phylogeny and amino acid composition. 
The reference ORF8 sequence YP 009724396 was found to be much 
more like the variants QMT48896.1 and QMI92505.1, which are more 
like each other as depicted in the sequence-based phylogeny (Fig. 7A). 
This sequence-based similarity of the QMT48896.1 and QMI92505.1 
ORF8 proteins is illustrated in the chronology of mutations. Similarly, 
S.S. Hassan et al.                                                                                                                                                                                                                               
Computers in Biology and Medicine 133 (2021) 104380
10
the mutation flow of the sequences QMT96239.1 and QMU92030.1 is 
supported by the respective sequence-based similarity. The network of 
five ORF8 protein variants from the US is justified based on the similar 
amino acid compositions/conservations across the five sequences. 
2.10. Flow-II 
We observed one sequence with first-order mutations in this flow of 
mutations, where only one mutation accumulated in the sequence 
(Fig. 7B). Additionally, four sequences (all are from the US) were 
identified with second-order mutations, suggesting that four sequences 
were found to have two mutations. The protein sequence QLY90504.1 
possesses a second mutation at position 67, which changed the hydro-
philic serine (S) to the hydrophobic phenylalanine (F). Therefore, it may 
account for disrupting the ionic interactions as it is a neutral mutation, 
the corresponding sequence accumulated two neutral mutations. The 
protein sequence QLH58953.1 acquired a second mutation, P38S, which 
was found to be of the disease-increasing type, and the hydropathy also 
Fig. 7. Possible flow of mutations in ORF8 evolution. (A–E) The possible flow of mutations in the ORF8 (SARS-CoV-2) sequences isolated in the US, Australia, US, 
US and Saudi Arabia, Australia. (Right panel) Phylogenetic relationship based on amino acid sequence similarity and amino acid composition (right) of ORF8 proteins 
of SARS-CoV-2 in US, Australia, US, US and Saudi Arabia, Australia. 
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changed from hydrophobic to hydrophilic, indicating that these muta-
tions may be of some importance. The protein sequence QLH58821.1 
possesses a second mutation, V62L, which was found to be of the 
disease-neutral type with no hydropathy change. Here, this sequence 
accumulated two neutral mutations, which may account for some 
functional changes. By comparing both the sequence-based phylogeny 
and amino acid conservation-based phylogeny, we found that according 
to sequence-based phylogeny, the Australian sequence is closely related 
to the ORF8 Wuhan sequence. However, according to the pathway, it 
should be closely related to both the Wuhan sequence and second-order 
mutations. This can be attributed to the presence of 119 amino acid 
residues instead of 121 amino acid residues. In this case, the sequence 
has two amino acid deletions. Therefore, it is present at the first node. 
2.11. Flow-III 
We analyzed the US sequences considering the Wuhan sequence (YP 
009724396.1) as the reference and found one sequence, QKC05159.1, 
with a single mutation and seven sequences with two mutations each 
(Fig. 7C). The first sequence, QKC05159.1, contained the L84S mutation 
(strain-determining mutation), neutral. However, the hydropathy 
changed from hydrophobic to hydrophilic, which may account for some 
significant change of a function. The sequences that accumulated a 
second mutation along with L84S are as follows: 
QMT28672.1: This sequence possesses a second mutation V5F, 
which was predicted to be of neutral type with no hydropathy change. 
Hence this sequence acquired two neutral mutations, and together these 
mutations may alter the protein’s function. 
QMS53022.1: This protein sequence acquired a second mutation at 
position 11, which changed the hydrophilic threonine (T) to the hy-
drophobic isoleucine (I), affecting the ionic interactions. This mutation 
was found to be a disease-increasing type, so it may affect the protein 
structure. 
QMT50804.1: This sequence gained a second mutation, E19D, 
which was predicted to be of the disease-increasing type with no hy-
dropathy change. The sequence first accumulated a neutral mutation 
then a disease-increasing mutation, signifying that these mutations may 
have some functional importance. 
QJD48694.1: H112Q occurred as a second mutation in this 
sequence, which was found to be of the disease-increasing type with no 
hydropathy change. Consequently, these mutations may contribute to 
the immune evasion property of the virus. 
QKV06506.1: This sequence possesses the S67F mutation, which 
was predicted to be of neutral type, and changed the hydrophilic serine 
(S) to the hydrophobic phenylalanine (F), thus interfering with the ionic 
interactions that potentially increase or decrease the affinity of the viral 
protein for a particular host cell protein. 
QKV40062.1: This sequence acquired a second mutation at Q72H, 
which was found to be a neutral mutation, and no change in hydropathy 
was observed. As this sequence accumulated two neutral mutations, it 
can be assumed that neutral mutations also have significant importance. 
QKV07730.1: The T11A mutation occurred as the second mutation 
in this sequence, which was predicted to be of the disease-increasing 
type, and the hydropathy was changed from hydrophilic to hydropho-
bic. Hence the structure and function of the protein are expected to 
differ. 
From the sequence-based phylogeny, it was observed that the Wuhan 
sequence was the first to originate. Although QKC05159.1 is the first 
sequence in our flow considering the time, it was found that in the 
phylogenetic tree, it is present at the fourth node instead of the second 
node, which is probably due to the presence of ambiguous mutations in 
this sequence. It was also determined that QKV07730.1 is very similar to 
QMT50804.1, and QMT28672.1 was observed to be similar to 
QKV07730.1 and QMT50804.1. All the other sequences have second- 
order mutations and are closely related to each other and follow the 
chronology. From the amino acid-based analysis, the Wuhan sequence 
has a high sequence similarity to QKV06506.1, thus proving that this 
sequence was identified chronologically after the Wuhan sequence 
QKC05159.1 and QMT28672.1, which again are very similar to each 
other. 
2.12. Flow-IV 
In another possible flow of mutations (Fig. 7D), we have found one 
sequence with a single mutation, six sequences with two mutations, and 
another two sequences with three mutations. The US sequence 
QKC05159.1 was identified to have the L84S mutation, which is a strain 
determining mutation, and was predicted to be a neutral mutation 
where hydropathy was changed from hydrophobic to hydrophilic. The 
sequences that accumulated second mutations along with L84S are the 
following, and it should be noted that the mutational accumulation 
occurred in a single strain: 
QMS54342.1: This US sequence acquired the E110Q mutation, 
which was predicted to be of the disease-increasing type, where no 
change in hydropathy was observed, and consequently, it may 
contribute to virulence properties of the virus. 
QLH01196.1: The A65S mutation occurred as a second mutation in 
this US sequence, which was found to be of neutral type. However, the 
hydropathy changed from hydrophobic to hydrophilic, thus potentially 
influencing the function of the protein. 
QMU91334.1: This US sequence possesses the D63G mutation, 
which was predicted to be of neutral type. However, the hydropathy 
changed from hydrophilic to hydrophobic so, this sequence accumulated 
two neutral mutations, which may allow the virus to evolve in terms of 
virulence. 
QMU91550.1: This US sequence mutated at position 62, which 
changed valine (V) to leucine (L), thereby mostly keeping the protein’s 
hydrophobicity unchanged. It was a neutral mutation even though it 
may influence the virulence properties of the protein. This sequence was 
followed by another sequence, QKG86865.1, with a third mutation at 
position 36, which changed the hydrophobic proline (P) to the hydro-
philic serine (S). Thus, the mutation was neutral, thus accumulating two 
neutral and one disease-increasing mutation, being significant for the 
evolution of the virus. We identified one more sequence, QLH57924.1, 
which possesses a third mutation, F16L, which was predicted to be 
neutral, and no hydropathy change was observed. This sequence ac-
quired three neutral mutations that may promote virus survival. 
QKU37052.1: This sequence with the W45L mutation was reported 
in Saudi Arabia, which was found to be of the disease-increasing type 
with no hydropathy change. Therefore, this sequence also accumulated 
one neutral and one disease-increasing mutation, affecting both the 
protein’s structure and function. 
QMT96539.1: The F104S mutation was reported in the US sequence, 
which was found to be of a disease-increasing type, and the hydropathy 
changed from hydrophobic to hydrophilic. Altogether, the sequence 
possesses one neutral and one disease-increasing mutation that may 
allow the virus to acquire new properties for better survival strategies. 
Sequence-based phylogeny suggested that the Wuhan sequence origi-
nated first. 
Due to ambiguous amino acids, the sequence QKC05159.1 was not 
observed close to be close to the Wuhan sequence. QKG86865.1 and 
QLH57924.1 were found to have third-order mutations, and they are 
assumed to be closely related by the flow, and the same has been sup-
ported by amino acid conservation-based phylogeny. 
2.13. Flow-V 
QJR88780.1 (Australia) possesses the mutation L84S compared to 
the Wuhan ORF8 sequence YP 009724396.1 (Fig. 7E). Another 
sequence, QJR88936.1, was reported, which possesses a second muta-
tion, V62L. This mutation was predicted to be neutral with no change in 
hydropathy. However, the hydrophobicity increased. This sequence 
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belongs to a particular strain and acquires two neutral mutations, 
indicating that these mutations may play some vital role in the function 
of ORF8a. As shown in both the sequence-based phylogeny and amino 
acid conservation-based phylogeny, the Wuhan sequence originated 
earlier, and the sequences QJR88780.1 and QJR88936.1 are more 
closely related to each other than to the Wuhan sequence as both se-
quences have one common mutation not present in the Wuhan sequence. 
3. Discussion 
Among SARS-CoV-2 proteins, the ORF8 accessory protein is unique 
because it plays a vital role in bypassing the host immune surveillance 
mechanism. This protein is found to have a wide variety of mutations, 
and among them, L84S (23) and S24L (7) have the highest frequency of 
occurrence, which bears distinct functional significance. It has been 
reported that L84S and S24L show antagonistic effects on protein folding 
stability of the SARS-CoV-2 ORF8 [48]. L84S destabilizes protein, 
thereby up-regulating host-immune activity and S24L positively favors 
folding stability, thus enhancing the functionality of the ORF8 protein. 
L84S is already established as a strain-determining mutation, and since, 
according to our studies, both L84S and S24L do not occur together in a 
single sequence of the SARS-CoV-2 ORF8 protein, it is proposed that 
virus with the S24L mutation is a new strain altogether. We also 
observed that hydrophobic to hydrophobic mutations are dominant in 
the D1 domain. Therefore, hydrophobicity is an essential property for 
the N-terminal signal peptide. However, in the D2 domain, hydrophobic 
to hydrophilic mutations are observed more frequently, consequently 
making the ionic interactions more favorable and allowing the protein to 
evolve, providing better pathogenicity efficacy. 
The ORF8 sequence of SARS-CoV-2 shows 93% similarity with the 
Bat-RaTG13-CoV and 88% similarity with that of the Pangolin-CoV 
ORF8. Thus, the ORF8 protein of SARS-CoV-2 can be considered a 
valuable candidate for deterministic evolutionary studies and the 
determination of the origin of SARS-CoV-2. We also analyzed a wide 
variety of mutations in the SARS-CoV-2 ORF8, where we compared them 
with the ORF8 of Bat-RaTG13-CoV and the Pangolin-CoV in relation to 
charge and hydrophobicity. We found that the Bat-RaTG13-CoV ORF8 
protein exhibits precisely the same properties as that of the SARS-CoV-2 
ORF8 protein, whereas the properties of the Pangolin-CoV ORF8 are 
relatively less similar to the SARS-CoV-2 ORF8. Furthermore, to study 
the evolutionary nature of mutations in the ORF8, we aligned three bat 
sequences and found that two of them were the same, and there were 
only six amino acid differences in the third compared to the other two 
sequences. So, only two variants were identified for the Bat-RaTG13- 
CoV ORF8. Therefore, it shows that the mutation rate is slow in the 
Bat-RaTG13-CoV ORF8. 
However, for pangolins, no differences were observed among four 
Pangolin-CoV ORF8 sequences, and therefore, only a single variant of 
ORF8 was identified. The Bat-RaTG13-CoV, the Pangolin-CoV, and the 
SARS-CoV-2 ORF8 displayed a high similarity index based on sequence 
alignment, biochemical characteristics, and secondary structure analysis 
[51]. Additionally, in the ORF8 of SARS-CoV-2, specific mutations were 
found to exhibit exact reversal regarding bats and pangolins and, 
therefore, point towards the genomic origin of SARS-CoV-2. However, 
unlike Bat-RaTG13-CoV and Pangolin-CoV, the mutational distribution 
of SARS-CoV-2 ORF8 is widespread, ranging from position 3 to 121, 
having no defined conserved region. This is a rather surprising obser-
vation. Furthermore, this property differentiates the SARS-CoV-2 ORF8 
from Bat-RaTG13-CoV and Pangolin-CoV, raising the question of the 
natural path of evolution of mutations in SARS-CoV-2. 
We further predicted the types and effects of mutations of 95 se-
quences and grouped them into four clusters, and found that the disease- 
decreasing type mutations with decreasing effect on stability are more 
prominent. Consequently, it is hypothesized that these mutations are 
promoting viral survival. Furthermore, we tracked the possible flow of 
mutations following time and geographic locations and validated our 
proposal concerning sequence-based and amino acid conservation-based 
phylogeny and therefore putting forward the order of accumulation of 
mutations. We are aware of the need to confirm our prediction by 
structural biology data and experimental observations from in vitro and 
in vivo studies. However, the powerful tools in bioinformatics have 
allowed us to generate a reasonable basis for the potential effect of 
SARS-CoV-2 ORF8 mutations. 
4. Conclusions 
This study represents the results of a comprehensive analysis of the 
uniqueness of the pandemic-causing SARS-CoV-2 by focusing on one of 
its accessory proteins, the ORF8 protein. ORF8 is involved in modulating 
the adaptive host immunity and innate immune responses by surpassing 
interferon-mediated antiviral host responses. Our study relies heavily on 
bioinformatics to analyze the 87 unique mutations identified in the 
SARS-CoV-2 ORF8 protein, the phylogenetic comparison to bat and 
pangolin CoV ORF8 proteins and evaluation of the potential effect of the 
identified mutations on SARS-CoV-2 virulence. We acknowledge that 
our findings lack support from direct structural analyses and cell-based 
confirmations but believe that the data presented on ORF8 can provide a 
suitable basis for further explorations to improve our understanding of 
the essential functions of providing all potential means to tackle the 
current pandemic. In future endeavors, more critical studies on the 
ORF8 protein of SARS-CoV-2 are necessary for a better understanding of 
the importance of high-frequency mutations and their role related to the 
host immune system and to validate the origin of SARS-CoV-2 more 
precisely. 
5. Materials and methods 
5.1. Dataset of the ORF8 of SARS-CoV-2 
As of February 14, 2021, - 29,881 complete genomes of SARS-CoV-2 
were available on the NCBI (National Center for Biotechnology Infor-
mation) database. Each genome contains one gene for the accessory 
protein ORF8, and among them, only 127 sequences were found to be 
unique. The amino acid sequences of the ORF8 variants were exported in 
FASTA format using the file operations through MATLAB (version 
9.3.0.713579 (R2020a)). Among these 127 unique ORF8 sequences, 
only 96 ORF8 protein sequences contain various mutations, and the 
remaining sequences either do not possess any mutations or only 
ambiguous mutations. The present study focused on 96 ORF8 proteins. 
An ORF8 protein sequence (YP 009724396.1) of the SARS-CoV-2 
genome (NC 045512) from Wuhan, China, was used as the reference 
to identify mutations [52]. 
The ORF8 protein sequences of SARS-CoV, Pangolin-CoV, and Bat- 
RaTG13-CoV were retrieved from the NCBI as reference sequences for 
understanding the proximal evolutionary origin of the SARS-CoV-2 
ORF8 protein. The unique ORF8 variant was obtained among the four 
available Pangolin-CoV sequences (QIA48620.1, QIA48638.1, 
QIA48647.1, and QIQ54055.1), were retrieved along with three avail-
able ORF8 sequences of Bat-RaTG13-CoV (AVP78048.1, AVP78037.1, 
and QHR63307.1), of which two variants (QHR63307.1 and 
AVP78048.1) showed 96% sequence similarity. 
5.2. Structural modeling and visualization 
The structures of the SARS-CoV-2 ORF8 and the SARS-CoV ORF7a 
have been retrieved from Protein Data Bank bearing with the accession 
number ID:7JTL (www.rcsb.org) and the accession number 6W37 (www 
.rcsb.org), respectively. All other ORF8 structures i.e., ORF8a and 
ORF8b of SARS-CoV, ORF8 of Bat-RaTG13-CoV, and Pangolin-CoV were 
modeled using the Swiss Model server [53] since ITASSER was not 
available due to server maintenance. The structures were analyzed and 
visualized using the UCSF ChimeraX tool [54]. The plotting was done by 
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using ORIGIN8 software. PDBsum database has been used to retrieve the 
SARS-CoV-2 ORF8 protein structure information, including the 2D sec-
ondary structure plot and interface regions [55]. 
5.3. Mutation identification 
Mutations are responsible for several genetic orders/disorders. 
Identifying these mutations requires novel detection methods, which 
have been reported in the literature [56]. In this study, each unique 
ORF8 sequence was aligned using NCBI protein p-BLAST and 
omega-blast suites to determine mismatches, and thereby missense 
mutations (amino acid changes) were identified [57,58]. For the effect 
of identified mutations, a web server Meta-SNP was used, and for the 
structural effects of mutations, another web server I-MUTANT was used 
[59,60]. The web server QUARK was used to predict the secondary 
structure of ORF8 proteins [61,62]. The mutation profiles have been 
presented using the Web-Logo3 server [63]. 
5.4. Amino acids compositions and phylogeny 
The frequency of occurrence of each amino acid Ai was determined 
for each primary sequence of ORF8 proteins. For all 96 ORF8 proteins, a 
twenty-dimensional frequency vector of amino acids was obtained. A 
distance matrix (Euclidean distance) was formed by measuring the 
distance (pairwise) between the twenty-dimensional frequency vectors 
for each ORF8 protein [64,65]. Thereby, applying the nearest 
neighbor-joining method, a phylogeny was derived from the distance 
matrix formed for each ORF8 protein of interest [66–68]. The following 
method was used to compute the distances of the new nodes to all other 
nodes at every iteration; the equation to calculate the distances between 
the new node, n, after joining i and j and all nodes (k), was the following:  
D(n, k) = a * D(i, k) + (1 − a) * D(j, k) − a * D(n, i) − (1 − a) * D(n, j)     
This equation could help us find the correct tree with additive data 
(minimum variance reduction). Note that, typically, equal variance and 
independence of evolutionary distance estimates (a = 1/2) are assumed 
[69]. The fundamental physicochemical properties were obtained by 
VOLPES, allowing unprecedented insights into the amino acid sequences 
of ORF8 variants among all species and in-depth exploration. 
5.5. The propensity of intrinsic disorder 
Per-residue disorder distribution in sequences of query proteins was 
evaluated by PONDR® VSL2 [70], one of the most accurate standalone 
disorder predictors [71–74]. The per-residue disorder predisposition 
scores are on a scale from 0 to 1, where 0 and 1 indicate fully ordered 
and disordered residues, respectively. Values above the threshold of 0.5 
are considered to correspond to disordered residues, whereas residues 
with disorder scores between 0.25 and 0.5 are considered highly flex-
ible, and residues with disorder scores between 0.1 and 0.25 are 
regarded as moderately flexible. 
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